Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07640906

AI-Assisted Chest-CT Reporting for Enhanced Speed and Quality (The DOUBLE-ACE Study)

The goal of this observational study is to learn if an AI assistant tool can help doctors who read chest CT scans (called radiologists) write their reports faster and just as well or better. Chest CT scans are common pictures taken of the inside of the chest to help with diagnosis. The main questions the study aims to answer are: (1) Does using the AI tool save radiologists time when writing their reports? (2) Are the final reports written with the AI tool's help as good as or better than reports written without it? To answer these questions, researchers will compare two time periods at several hospitals. They will look at how long it took to write reports and how good the reports were, both from a time before the AI tool was available and from a time after it was in regular use. In this study, radiologists will use the AI tool as part of their normal daily work. The tool is built into the computer system they already use to look at scans. Researchers will then measure the time and quality of the reports produced during their regular shifts.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China

Loading trial locations.

About this study

Here we provide a summary of the study's methodological framework, including a description of the AI system under evaluation, key quality control measures, and the data analysis plan. Comprehensive details regarding the full protocol, including eligibility criteria and outcome measures, can be found in the other modules of the study protocol.

  • Background on the AI System: The study evaluates a clinically deployed AI-assisted reporting system, built upon an advanced multimodal foundation model trained on a large-scale chest CT dataset. Its performance, reliability, and generalizability have been established through rigorous validation on extensive internal and external datasets. Prior reader studies have demonstrated its clinical utility by significantly reducing reporting time through automated draft generation while maintaining or improving report quality, supporting its integration into real-world workflow for this evaluation.
  • Quality Control: To ensure objective assessment, report quality will be scored by a panel of at least two independent, blinded thoracic radiologists using a standardized rubric, with inter-rater reliability calculated. A study-specific data dictionary and Standard Operating Procedures (SOPs) for data handling and analysis will be implemented to ensure reproducibility and auditability.
  • Data Analysis Plan: A comparative statistical analysis between pre- and post-implementation groups is planned. Appropriate statistical tests (e.g., Mann-Whitney U test, mixed-effects models) will be applied based on data distribution and variable type. A sample size calculation will be conducted to ensure the study is adequately powered to detect a clinically meaningful difference in the primary efficiency endpoint. The primary analysis will be a paired comparison of outcomes (e.g., report time, quality) between the two phases for the participants who complete both. To address potential attrition (e.g., radiologist turnover during the study year) and the influence of radiologist experience, the analysis plan includes: (1) Accounting for and reporting any participant dropout between phases. (2) Conducting pre-specified subgroup or stratified analyses based on radiologist seniority (e.g., junior vs. senior) to examine its effect on the outcomes.
  • Confounding Factor Control: To minimize potential bias, the study may identify collective variables (radiologists' sex, years of relevant professional experience, etc.) that may be considered potential confounding factors according to external experts' judgements. Certain patient-related information, such as diagnosis (infection, malignancy, cardiovascular disease, etc.) and clinical scenario (e.g., inpatient, outpatient, emergency), may also be collected retrospectively, where necessary, to evaluate model performance within specific diagnostic subgroups. The study will adopt multiple possible approaches for confounding factor adjustment or analysis, which may include stratified analyses and other related statistical methods.
  • Potential Adjustments in Study Protocol or Analysis Methods: As the study may involve multiple centers, in case of ethical or administrative restrictions at certain time at specific sites, AI assistance may be temporarily suspended to approximate the scenario without AI assistance at those sites. In such cases, the corresponding results may be reported as the with-AI and without-AI phases, rather than labeling them as baseline and AI-available phases. Furthermore, radiologists who decline to provide demographic or occupational information (e.g., years of professional experience or sex)-variables that may serve as potential confounders-will be excluded from adjusted and stratified analyses that require such covariates. These approaches may need to be incorporated into confounding factor or stratified analyses, and we may update related conditions accordingly when necessary.

Who can participate

Only the study team can determine whether someone qualifies for participation.

The study participants include both the radiologists whose performance is evaluated and the chest CT scans they interpret. Eligibility criteria are defined for both.

  • Inclusion Criteria

1.1 For Radiologists

  • Board-certified radiologists specializing in or routinely performing thoracic imaging.
  • Employed at one of the participating study centers for the entire duration of both the without-AI and with-AI study periods.
  • Interpreted a minimum of eligible chest CT scans (e.g., > 50 scans) during both the without-AI and with-AI data collection periods.

1.2 For Chest CT Scans

  • Non-contrast chest CT examinations performed for any clinical indication.
  • Scans completed and finalized during the defined with-AI or without-AI study periods.
  • Patient age 18 years or older at the time of the scan.
  • Exclusion Criteria

2.1 For Radiologists:

  • Radiologists who joined, left, or were on extended leave (e.g., >4 weeks) from the participating center between the with-AI and without-AI study periods.
  • Radiologists who interpreted fewer than the minimum required number of eligible scans in either study period.
  • Radiologists who voluntarily decline to have their de-identified performance data included in the study analysis.
  • Radiologists who decline to provide demographic or occupational information (e.g., years of professional experience or sex)-variables that may serve as potential confounders-will be excluded from adjusted and stratified analyses that require such covariates.

2.2 For Chest CT Scans

  • CT scans of pediatric patients (age < 18 years).
  • Contrast-enhanced chest CT studies.
  • Studies performed for specific procedural guidance (e.g., biopsy, ablation).
  • Studies deemed technically inadequate for primary interpretation by radiologist (e.g., severe motion artifact, incomplete study).
  • Studies for which the AI system fails to generate a valid preliminary report draft. This includes possible system failures, algorithm errors, or cases where the generated draft is deemed technically unusable (e.g., empty, garbled, or based on critically flawed image analysis).
  • The lack of relevant information (diagnosis, clinical scenario, etc.). Chest CT data will be excluded from corresponding analyses if the required information, which is necessary for confounding control, subgroup analyses, or other pre-specified analyses, is unavailable. Such scenarios include data that cannot be retrospectively retrieved, incompletely recorded, or restricted due to ethical or institutional requirements.

Treatment and study plan

An AI-assisted reporting system integrated into the clinical workflow, providing automated draft generation to assist with chest CT interpretation

Device

The intervention under evaluation is an AI-assisted diagnostic reporting system, integrated directly into the radiologists' workflow. The system analyzes the CT images in real time using an AI model and automatically generates a structured, preliminary radiology report draft. The interpreting radiologist reviews this AI-generated draft, which is presented within their familiar reporting interface. The radiologist then actively edits, confirms, supplements, or overrides the draft content as necessary before finalizing and signing the report. This intervention is distinguished from other AI tools by its focus on end-to-end reporting efficiency via integrated draft generation within the radiologist's classic workflow. It moves beyond simple abnormality detection or highlighting by generating a complete, structured narrative report draft, aiming to reduce dictation/typing time and minimize oversight of findings.

Primary outcomes

  1. Change in Average Image Interpretation Time

    Time frame: Time of interpretation will be collected once the data become fully available (generally within 2 weeks after the planned primary completion date). Final aggregated analysis will be completed within 3 months after the collection of potential confounders.

    Comparison of the average time taken by participating radiologists to complete standard chest CT interpretation tasks, measured both with and without use of the automated interpretation tool. The time will be recorded from the start to the completion of each individual reading case.

  2. Change in Chest CT Report Quality Score

    Time frame: Reports will be distributed to external experts for scoring once the data become available, with scoring results returned within 7 days. Final aggregated analysis will be completed within 3 months after the collection of potential confounders.

    Comparison of the subjective quality of chest CT reports written with and without automated tool support. Blinded external experts will evaluate the subjective quality of all sampled reports using a 10-point rating scale, with scores ranging from 1 (poorest quality) to 10 (highest quality).

Other outcomes

  1. Radiologist Editing Intensity on AI-Generated Report Drafts

    Time frame: Report texts will be collected once the data become fully available (generally within 2 weeks after the planned primary completion date). Final aggregated analysis will be completed within 3 months after the collection of potential confounders.

    This measure quantifies the extent of modification a radiologist makes to the initial draft report generated by the AI system. Editing intensity will be algorithmically calculated for each report in the with-AI period. A common method is the normalized edit distance (e.g., Levenshtein distance) or the percentage of text modified between the AI-generated draft and the radiologist's final signed report.

Study contacts

Contact information is provided by the study sponsor or research team.

Weiqiu Jin, MD

CONTACT

[email protected]

Xiaodan Ye, MD, PhD

CONTACT

[email protected]

+86-13761459998

Sponsors and collaborators

Lead sponsor

Shanghai Zhongshan Hospital

Other

Registry information

Official study title

A Multicenter Comparative Study Evaluating the Impact of an AI-Assisted Chest CT Reporting System on Real-world Radiologist Performance: The DOUBLE-ACE Study

Acronym: DOUBLE-ACE

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jun 11, 2026
Registry last updated
Jun 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.